Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,792 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The pharmacokinetics of rituximab following an intravitreal injection.
Kim H, Csaky KG, Chan CC, Bungay PM, Lutz RJ, Dedrick RL, Yuan P, Rosenberg J, Grillo-Lopez AJ, Wilson WH, Robinson MR. Kim H, et al. Among authors: rosenberg j. Exp Eye Res. 2006 May;82(5):760-6. doi: 10.1016/j.exer.2005.09.018. Epub 2005 Nov 11. Exp Eye Res. 2006. PMID: 16289160
Rituximab: the first monoclonal antibody approved for the treatment of lymphoma.
Grillo-López AJ, White CA, Dallaire BK, Varns CL, Shen CD, Wei A, Leonard JE, McClure A, Weaver R, Cairelli S, Rosenberg J. Grillo-López AJ, et al. Among authors: rosenberg j. Curr Pharm Biotechnol. 2000 Jul;1(1):1-9. doi: 10.2174/1389201003379059. Curr Pharm Biotechnol. 2000. PMID: 11467356 Review.
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment.
Rubenstein JL, Combs D, Rosenberg J, Levy A, McDermott M, Damon L, Ignoffo R, Aldape K, Shen A, Lee D, Grillo-Lopez A, Shuman MA. Rubenstein JL, et al. Among authors: rosenberg j. Blood. 2003 Jan 15;101(2):466-8. doi: 10.1182/blood-2002-06-1636. Epub 2002 Sep 5. Blood. 2003. PMID: 12393404 Free article.
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma.
Berinstein NL, Grillo-López AJ, White CA, Bence-Bruckler I, Maloney D, Czuczman M, Green D, Rosenberg J, McLaughlin P, Shen D. Berinstein NL, et al. Among authors: rosenberg j. Ann Oncol. 1998 Sep;9(9):995-1001. doi: 10.1023/A:1008416911099. Ann Oncol. 1998. PMID: 9818074 Free article. Clinical Trial.
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy.
Czuczman MS, Grillo-López AJ, McLaughlin P, White CA, Saleh M, Gordon L, LoBuglio AF, Rosenberg J, Alkuzweny B, Maloney D. Czuczman MS, et al. Among authors: rosenberg j. Ann Oncol. 2001 Jan;12(1):109-14. doi: 10.1023/a:1008395214584. Ann Oncol. 2001. PMID: 11249036 Free article. Clinical Trial.
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity.
Byrd JC, Murphy T, Howard RS, Lucas MS, Goodrich A, Park K, Pearson M, Waselenko JK, Ling G, Grever MR, Grillo-Lopez AJ, Rosenberg J, Kunkel L, Flinn IW. Byrd JC, et al. Among authors: rosenberg j. J Clin Oncol. 2001 Apr 15;19(8):2153-64. doi: 10.1200/JCO.2001.19.8.2153. J Clin Oncol. 2001. PMID: 11304767 Clinical Trial.
2,792 results